Error in Methods - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction to the Methods: Center Subfield Diameter Unit in the Aflibercept 8 mg PULSAR Analysis

  • October 1, 2026

Share

Clinical Scorecard: Correction to the Methods: Center Subfield Diameter Unit in the Aflibercept 8 mg PULSAR Analysis

At a Glance

CategoryDetail
ConditionNot specified in the correction notice.
Key MechanismsMechanisms or clinical associations described in the source article.
Target PopulationPatients or participants described in the source article.
Care SettingCare setting described in the source article.

Key Highlights

  • An online correction was issued for the post hoc PULSAR analysis of aflibercept 8 mg in polypoidal choroidal vasculopathy.
  • The original investigation appeared online on December 18, 2025, and in the February 2026 issue.
  • In the Methods section, the center subfield diameter unit was corrected from 1 cm to 1 mm.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Not specified in the correction notice.

          The correction notice concerns a Methods unit correction; it provides no prescribing information.

          Clinical Best Practices

            Related Resources & Content

            Original Source(s)

            Error in Methods

            • October 1, 2026

            Related Content

            Vitreous cyst may hide behind chronic floaters

            Imaging revealed a free-floating pigmented cyst after more than 20 years of symptoms.

            Case links red light mask to secondary glaucoma

            Ciliochoroidal effusions accompanied severe intraocular pressure elevation following recent use of an at-home red light therapy device.

            Addressing the Emergency-Care Burden in Ophthalmology—Keeping an Eye on the Call